Comparative Study
doi: 10.1016/j.canlet.2005.05.040.
Epub 2005 Jul 11.
SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines
Affiliations
- PMID: 16009488
- DOI: 10.1016/j.canlet.2005.05.040
Item in Clipboard
Comparative Study
SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines
Cancer Lett.
.
Abstract
A novel hybrid synthetic histone deacetylase inhibitor, SK-7041, was synthesized from hydroaxamic acid of trichostatin A (TSA) and pyridyl ring of MS-275. TSA and SK-7041 both induced apoptosis and G2-M cell cycle arrest in pancreatic cancer cell lines. The expressions of p21 and cyclin D2 were up-regulated and that of cyclin B1 was down-regulated by TSA or SK-7041. The expression levels of Mcl-1 and Bcl-XL but not those of Bcl-2, Bax, and Bak were suppressed by TSA or SK-7041 treatment. SK-7041 or TSA induced apoptosis and G2-M cell cycle arrest by up-regulating p21 and down-regulating cyclin B1, Mcl-1, and Bcl-XL.
Similar articles
-
Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.Clin Cancer Res. 2004 Aug 1;10(15):5271-81. doi: 10.1158/1078-0432.CCR-03-0709. Clin Cancer Res. 2004. PMID: 15297431
-
Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.Endocr Relat Cancer. 2006 Dec;13(4):1237-50. doi: 10.1677/erc.1.01249. Endocr Relat Cancer. 2006. PMID: 17158768
-
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.Mol Carcinog. 2003 Oct;38(2):59-69. doi: 10.1002/mc.10145. Mol Carcinog. 2003. PMID: 14502645
-
Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase.Ann N Y Acad Sci. 1999;886:200-3. doi: 10.1111/j.1749-6632.1999.tb09416.x. Ann N Y Acad Sci. 1999. PMID: 10667219 Review. No abstract available.
-
[Alternative means of drug therapy for cancer: antineoplastons--antitumor properties and mechanisms of action].Vopr Onkol. 2014;60(4):449-56. Vopr Onkol. 2014. PMID: 25552063 Review. Russian.
Cited by
-
Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Cancer Lett. 2012 Jul 28;320(2):138-49. doi: 10.1016/j.canlet.2012.03.007. Epub 2012 Mar 13. Cancer Lett. 2012. PMID: 22425961 Free PMC article. Review.
-
Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects.Oncol Ther. 2016;4(1):73-89. doi: 10.1007/s40487-016-0023-1. Epub 2016 Jun 10. Oncol Ther. 2016. PMID: 28261641 Free PMC article. Review.
-
Advances in pancreatic cancer epigenetics: From the mechanism to the clinic.World J Gastrointest Oncol. 2025 Jul 15;17(7):106238. doi: 10.4251/wjgo.v17.i7.106238. World J Gastrointest Oncol. 2025. PMID: 40697230 Free PMC article. Review.
-
Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential.Pharmaceuticals (Basel). 2025 Apr 11;18(4):563. doi: 10.3390/ph18040563. Pharmaceuticals (Basel). 2025. PMID: 40283998 Free PMC article. Review.
-
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.Epigenetics. 2015;10(5):431-45. doi: 10.1080/15592294.2015.1039216. Epigenetics. 2015. PMID: 25923331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
